Japanese BAY86-9766 Monotherapy Phase I Study

NCT01179295 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
12
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Bayer